Jason Adair
Corporate Officer/Principal at Liquidia Technologies, Inc.
Net worth: 1 M $ as of 2024-04-29
Jason Adair active positions
| Companies | Position | Start | End |
|---|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 2016-01-13 | - |
Career history of Jason Adair
Former positions of Jason Adair
| Companies | Position | Start | End |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2011-07-31 | 2015-11-30 |
| LIQUIDIA CORPORATION | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | - | - |
Training of Jason Adair
| Wake Forest University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Stock Market
- Insiders
- Jason Adair
- Experience
